DAIsy
Developing AI ecosystems improving diagnosis and care of mental diseases
Project description
Major depressive disorder (MDD) is a common psychiatric disorder, ranking as the second leading contributor of years
lived with disability. Finding the right approach for individual patients remains challenging. DAIsy will develop and bring
to the market AI-supported solutions for improved diagnosis, treatment selection, diet monitoring, activity tracking,
support in behaviour adjustments, and treatment response assessment. Novel AI techniques will be jointly developed
to advance the AI applicability for these fragile patients by advancing techniques for large data points/patient ratios,
improving explainability and uncertainty quantification.
Germany
Netherlands
5M Software
Netherlands
Academic Medical Centre Amsterdam (AMC)
Netherlands
Eindhoven University of Technology
Netherlands
GGZ Oost-Brabant
Netherlands
KnowL Solutions B.V.
Netherlands
Philips
Netherlands
SemLab
Netherlands
Portugal
FYI DIGITAL INNOVATION
Portugal